Sort
78,016 grants matching “breast cancer”
Comparative modeling of multiple myeloma across myeloma control continuuum: prevention, treatment, and disparity reduction
$632,304Su-Hsin Chang · Washington University · U01 · FY2023 · CA
Role of tumor heterogeneity on receptor engagement
$632,224Xavier Intes · Rensselaer Polytechnic Institute · R01 · FY2017 · CA
A Randomized Trial of Physical Activity for Cognitive Functioning in Breast Cancer Survivors
$632,213Sheri J Hartman · University Of California, San Diego · R01 · FY2020 · CA
Individualized medicine to predict and prevent chemotherapy-related heart failure
$632,207Nadine Norton · Mayo Clinic Jacksonville · R01 · FY2024 · HL
Risk Factors for Second Primary Breast Cancer Among DCIS Survivors
$632,199Christopher I Li · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Genetic Susceptibility And The Environment In Cancer Risk
$632,196Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2015 · ES
Mitochondrial iron export therapy for doxorubicin-induced cardiotoxicity
$632,159Jonghan Kim · University Of Massachusetts Lowell · R01 · FY2025 · HL
Biobehavioral predictors of fatigue in newly-diagnosed breast cancer patients
$632,148Julienne E Bower · University Of California Los Angeles · R01 · FY2012 · CA
Macro-vasculature: A Novel Image Biomarker of Lung Cance
$632,139Jiantao Pu · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Investigating Environmental Risk Factors for Breast Cancer Using Adductomics
$632,114William E Funk · Northwestern University At Chicago · R01 · FY2024 · ES
Development of a cell-penetrating beta-catenin antagonist peptide as a therapeutic candidate for Wnt-driven breast cancer
$632,111Jim Rotolo · Sapience Therapeutics, Inc. · R44 · FY2024 · CA
DEFINE THE TWIST-ATX-LPAR1 SIGNALING AXIS IN PROMOTING OBESITY-ASSOCIATED TRIPLE-NEGATIVE BREAST CANCER
$632,100University Of Kentucky Research Foundation, The · · FY2016 · Department of the Army
A randomized trial of lifestyle guidelines on breast cancer biomarkers and treatment adherence
$632,034Tara B Sanft · Yale University · R01 · FY2019 · CA
Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor
$632,028John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2017 · CA
Secondary Prevention through Surveillance and Intervention
$632,007Lewis A Chodosh · University Of Pennsylvania · R01 · FY2019 · CA
Antioxidant supplements, genetics, and chemotherapy outcomes
$631,996Christine B. Ambrosone · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA
Small-molecule degraders of BET proteins
$631,956Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Sleep and Cancer: Evaluation of Risk and Insights into Mechanisms
$631,932Peggy Reynolds · Cancer Prevention Instit Of California · R01 · FY2017 · CA
Optimizing Individualized and Adaptive mHealth Interventions via Control Systems Engineering Methods
$631,918Eric Hekler · University Of California, San Diego · R01 · FY2021 · CA
MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response
$631,914Jun He · Thomas Jefferson University · R01 · FY2023 · CA
High-flow microfluidics of leukapheresis blood products for functional analysis of breast circulating tumor cells
$631,907Mehmet Toner · Massachusetts General Hospital · R01 · FY2022 · CA
Impact of exercise on ovarian cancer prognosis
$631,739Melinda L Irwin · Yale University · R01 · FY2011 · CA
Perfluoroalkyl Substances and the Gut Microbiome and Fecal Metabolome: Implications for Obesity Risk in Hispanic Children
$631,708Tanya Lynn Alderete · Johns Hopkins University · R01 · FY2025 · ES
Understanding and addressing rejection of personalized cancer risk information
$631,686Laura D. Scherer · University Of Colorado Denver · R01 · FY2025 · CA
COOPERATIVE FAMILY REGISTRY FOR BREAST CANCER STUDIES
$631,665University Of Utah · U01 · FY2002 · CA